Impact of Male Partner Involvement on Women’s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial
Elizabeth Montgomery(RTI International), Nishanta Singh(South African Medical Research Council), Zakir Gaffoor(South African Medical Research Council), Samantha Siva, Krishnaveni Reddy(Perinatal HIV Research Unit), Sarah T. Roberts(RTI International), Jared M. Baeten(University of Washington), Thesla Palanee‐Phillips(University of the Witwatersrand), Vaneshree Govender(South African Medical Research Council), Flavia Matovu Kiweewa(MUJHU Research Collaboration), Katie Schwartz(University of Wyoming), Samuel Kabwigu(MUJHU Research Collaboration), Gonasagrie Nair, Kalendri Naidoo(RTI International)
Cited by 47
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768
Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2
|New England Journal of Medicine|2010|532
Infection with <i>Trichomonas vaginalis</i> Increases the Risk of HIV‐1 Acquisition
|The Journal of Infectious Diseases|2007|481